ALLMedicine™ Pancreatitis Center

Oct 23rd, 2021 - Several factors have been suggested to mediate pain in patients with chronic pancreatitis. However, it is unknown whether these factors are overlapping and if they have cumulative effects on patient-reported outcomes (PROs). We performed a multice...

Oct 22nd, 2021 - Hurdles in ERCP trials: do we need to change the diagnostic criteria for post-ERCP pancreatitis?|2021|Chong B,Cote GA,|

Oct 20th, 2021 - Acute pancreatitis (AP) occurs among patients with pancreas-sufficient cystic fibrosis (PS-CF) but is reportedly less common among patients with pancreas-insufficient cystic fibrosis (PI-CF). The incidence of AP may be influenced by cystic fibrosi...

Oct 19th, 2021 - GOALS AND OBJECTIVES Hypothesis: Caloric restriction with increased physical activity integrated into induction chemotherapy will decrease chemoresistance and reduce minimal residual disease (MRD). In children receiving induction therapy for NCI/R...

Oct 19th, 2021 - The pancreas is a bifunctional organ with both endocrine and exocrine components. A number of pathologies can afflict the pancreas, including diabetes, pancreatitis, and pancreatic cancer. All three of these diseases mark active areas of study, no...

Nov 2nd, 2020 - EUS remains a primary diagnostic tool for the evaluation of pancreaticobiliary disease. Although EUS combined with FNA or biopsy sampling is highly sensitive for the diagnosis of neoplasia within the pancreaticobiliary tract, limitations exist in ...

Sep 21st, 2020 - This guideline will provide the practicing endocrinologist with an approach to the assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of preventing cardiovascular (CV) events and triglyceride-induced p...

Aug 15th, 2020 - This paper is part of the international consensus guidelines on chronic pancreatitis, presenting for interventional endoscopy. An international working group with experts on interventional endoscopy evaluated 26 statements generated from evidence ...

Jul 8th, 2020 - Chronic pancreatitis (CP) is a complex inflammatory disease with variable presentations and outcomes. This statement is part of the international consensus guidelines on CP, specifically on the diagnostic role of endoscopic ultrasound (EUS). An in...

Jul 7th, 2020 - Patients with chronic pancreatitis (CP) have an increased risk of pancreatic cancer. We present the international consensus guidelines for surveillance of pancreatic cancer in CP. The international group evaluated 10 statements generated from evid...

Oct 19th, 2021 - GOALS AND OBJECTIVES Hypothesis: Caloric restriction with increased physical activity integrated into induction chemotherapy will decrease chemoresistance and reduce minimal residual disease (MRD). In children receiving induction therapy for NCI/R...

Oct 13th, 2021 - Coronavirus-induced disease 2019 (COVID-19) caused by SARS-CoV-2 infection is a highly contagious disease with a high and unpredictable morbidity and mortality, for which there is currently no specific treatment. Progression from a mild fatigue, f...

Oct 11th, 2021 - Chronic gastritis (CG) is a very common disease. The incidence of CG is not accurately known. However, it is clear that the incidence of CG is increasing by advancing age. CG is divided into two main types; type A or immune and type B or non-immun...

Oct 6th, 2021 - Cannulation success with standard techniques reported to be around 95% even in expert hands and despite all efforts, it can be challenging that needs an alternate intervention. NKF is recommended as the initial technique for pre-cutting because th...

Oct 6th, 2021 - The aim of this prospective mono-institutional phase II study is to assess the efficacy and safety of sequentially integrated treatment of FOLFIRINOX or Gemcitabine-Abraxane and SBRT with a total dose of 54 Gy in 6 fractions of 9 Gy /fractions in ...

Oct 7th, 2021 - (Reuters Health) - Immediately draining an infected necrotizing pancreas does not prevent complications any better than postponing the procedure, according to a new test in 104 patients reported in the New England Journal of Medicine. Immediate dr...

Oct 6th, 2021 - Kathleen Madden, FNP, MSN, AOCNP, APHN, APHN Being able to quickly detect and properly manage adverse events (AEs) that arise in patients with melanoma who are receiving immunotherapy is key to improving their experience with treatment, explained...

Oct 6th, 2021 - The combination of atezolizumab (Tecentriq) plus bevacizumab (Avastin) elicited encouraging, durable responses in patients with advanced malignant peritoneal mesothelioma, irrespective of tumor mutational burden (TMB) and PD-L1 expression status, ...

Oct 6th, 2021 - Igor Puzanov, MD, MSCI, FACP Director, Early Phase Clinical Trials Program Chief of Melanoma Section Co-Leader, CCSG Experimental Therapeutics Program Professor of Oncology in the Department of Medicine Roswell Park Cancer Institute Immune...

Oct 6th, 2021 - Rosa Hwang, MD An investigational antibody directed against Dickkopf-3 (DKK3) may be the key in suppressing tumor growth and extending survival in patients with pancreatic adenocarcinoma, according to a recent preclinical study published in Scien...